SECOND AMENDMENT TO AGREEMENT AND PLAN OF MERGER

                                                                   EXHIBIT 2.3



                               SECOND AMENDMENT
                                      TO
                         AGREEMENT AND PLAN OF MERGER


      This Second Amendment to Agreement and Plan of Merger (the "Amendment") is
dated effective as of June 17, 1998 among Corgenix Medical Corporation,  Inc., a
Nevada  corporation  (formerly  known as Xxxx Xxxx  Technologies,  Inc.)  ("Xxxx
Wolf") and TransGlobal  Financial  Corporation  ("TransGlobal").  This Amendment
amends that certain Agreement and Plan of Merger entered into as of May 12, 1998
among Reaads Medical  Products,  Inc., a Delaware  corporation  (the "Company"),
Corgenix and Xxxx Xxxx  Acquisition  Corp., a Delaware  corporation  ("Xxxx Wolf
Subsidiary"),  as amended by First  Amendment  thereto dated effective as of 
May 22, 1998 (as so amended, the "Merger Agreement").  Unless otherwise defined
herein, capitalized terms used in this Amendment have the meanings given to them
in the Merger Agreement.

                                   RECITALS

      Section 8(c) of the Merger Agreement, as amended, imposes on Xxxx Xxxx the
obligation to file a Registration  Statement to register the Xxxx Wolf Preferred
Shares, the Warrants and the Underlying Shares with the United States Securities
and Exchange  Commission  under the  Securities Act on Form X-0, XX-0 or another
appropriate registration form, such Registration Statement to be filed within 30
days after May 22, 1998, and to use its best efforts to cause such  Registration
Statement to be declared effective as expeditiously as possible and in any event
within a period of 60 days  thereafter.  If Xxxx Xxxx  fails to comply  with the
provisions of Section 8(c) of the Merger Agreement,  it is subject to liquidated
damages  payable  to  TransGlobal  of $1,000 for each day that Xxxx Wolf has not
complied with such obligation. Xxxx Xxxx and TransGlobal now desire to terminate
the obligation  under Section 8(c) of the Merger Agreement for Xxxx Wolf to file
a Registration Statement. Accordingly, for good and valuable consideration, Xxxx
Xxxx and TransGlobal do hereby agree as follows:

                                  AGREEMENT

      1.  Section 8(c) of the Merger Agreement is hereby deleted in its 
entirety. Xxxx Wolf shall have no obligation to file a Registration Statement
under the Securities Act to register its shares of Xxxx Xxxx Preferred Shares,
Warrants, or Underlying Shares.

      2.  Section 8(d) of the Merger  Agreement is hereby amended and restated 
in its entirety to read as follows:

          (d) EXCHANGE ACT REGISTRATION. Xxxx Wolf shall file a Registration
              Statement to register  Xxxx Xxxx under  Section  12(g) of the
              Exchange Act on Form 10, Form 10-SB or another form appropriate
              for such registration, and Xxxx Wolf shall use its best efforts
              to cause such Registration Statement to be filed as soon as
              practicable following the effective date of this Amendment.




      3. Except as specifically  set forth in this  Amendment,  all of the terms
and provisions of the Merger Agreement shall remain in full force and effect.


IN WITNESS  WHEREOF,  the Parties  hereto have executed this Amendment as of the
date first above written.


CORGENIX MEDICAL CORPORATION
(f.k.a. Xxxx Xxxx Technologies, Inc.)


     /S/ XXXXXXXX X. XXXXXXX
By: -------------------------------------
      Xxxxxxxx X. Xxxxxxx, President



TRANSGLOBAL FINANCIAL CORPORATION


     /S/ XXXX X. MUSTAFOGLU
By: -------------------------------------
      Xxxx X. Mustafoglu, President